Clinical Trial Update: The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer [Phase 1, Phase 2]

View source ↗

Summary

The document discusses an ongoing evaluation of CASAD for diarrhea related to medullary thyroid carcinoma across Phase 1 and Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medullary Thyroid Carcinoma

Drugs mentioned

• CASAD

Snippet

Sponsor: Salient Pharmaceuticals Incorporated | Conditions: Diarrhea, Medullary Thyroid Cancer | Phase 1, Phase 2 | Status: UNKNOWN